retatrutide phase 2 trial results weight loss with as compared to licenced obesity Retatrutide Results: How Much Weight
Description
[PubMed ID: 15126524]
Most GI symptoms improve over time once you're at a stable dose
GLP-1s improve survivorship in people with DCIS People with ductal carcinoma in situ (DCIS) are at higher risk of the cancer coming back if they also have obesity and/or diabetes
10.1038/nature10798 284
This treatment is recommended 3-4 times every 4-6 weeks
